Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. [electronic resource]
Producer: 20141117Description: 1142-51 p. digitalISSN:- 1349-7006
- Adenocarcinoma -- blood supply
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Benzamides -- pharmacology
- Celecoxib
- Cell Line, Tumor
- Cell Proliferation
- Cyclooxygenase 2 -- metabolism
- Drug Screening Assays, Antitumor
- Female
- Lung Neoplasms -- blood supply
- Lymphangiogenesis
- Lymphatic Metastasis
- Macrophages -- metabolism
- Mammary Neoplasms, Experimental -- blood supply
- Mice
- Mice, Inbred C3H
- Molecular Targeted Therapy
- Neoplasm Transplantation
- Neoplastic Stem Cells
- Neovascularization, Pathologic -- drug therapy
- Pyrazoles -- pharmacology
- Receptors, Prostaglandin E, EP4 Subtype -- antagonists & inhibitors
- Sulfonamides -- pharmacology
- Tumor Burden
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.